The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms
Abstract
The role of N 6 -methyladenosine (m6A) modifications in renal diseases is largely unknown. Here, we characterized the role of N 6 -adenosine-methyltransferase-like 3 (METTL3), whose expression is elevated in renal tubules in different acute kidney injury (AKI) models as well as in human biopsies and cultured tubular epithelial cells (TECs). METTL3 silencing alleviated renal inflammation and programmed cell death in TECs in response to stimulation by tumor necrosis factor–α (TNF-α), cisplatin, and lipopolysaccharide (LPS), whereas METTL3 overexpression had the opposite effects. Conditional knockout of METTL3 from mouse kidneys attenuated cisplatin- and ischemic/reperfusion (I/R)–induced renal dysfunction, injury, and inflammation. Moreover, TAB3 [TGF-β–activated kinase 1 (MAP3K7) binding protein 3] was identified as a target of METTL3 by m6A methylated RNA immunoprecipitation sequencing and RNA sequencing. The stability of TAB3 was increased through binding of IGF2BP2 (insulin-like growth factor 2 binding protein 2) to its m6A-modified stop codon regions. The proinflammatory effects of TAB3 were then explored both in vitro and in vivo. Adeno-associated virus 9 (AAV9)–mediated METTL3 silencing attenuated renal injury and inflammation in cisplatin- and LPS-induced AKI mouse models. We further identified Cpd-564 as a METTL3 inhibitor that had better protective effects against cisplatin- and ischemia/reperfusion-induced renal injury and inflammation than S -adenosyl- l -homocysteine, a previously identified METTL3 inhibitor. Collectively, METTL3 promoted m6A modifications of TAB3 and enhanced its stability via IGF2BP2-dependent mechanisms. Both genetic and pharmacological inhibition of METTL3 attenuated renal injury and inflammation, suggesting that the METTL3/TAB3 axis is a potential target for treatment of AKI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dynamic RNA Modifications in Gene Expression Regulation
Roundtree, I. A., Evans, M. E., Pan, T., & He, C. (2017) · Cell · doi:10.1016/j.cell.2017.05.045 · Cited by 3,399
Recognition of RNA N6-methyladenosine by IGF2BP proteins enhances mRNA stability and translation
Huang, H., Weng, H., Sun, W., Qin, X., Shi, H., Wu, H., Zhao, B. S., Mesquita, A., Liu, C., Yuan, C. L., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0045-z · Cited by 2,997
Self-citationReading, writing and erasing mRNA methylation
Zaccara, S., Ries, R. J., & Jaffrey, S. R. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0168-5 · Cited by 2,597
Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
Shi, H., Wei, J., & He, C. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.04.025 · Cited by 1,931
5′ UTR m6A Promotes Cap-Independent Translation
Meyer, K. D., Patil, D. P., Zhou, J., Zinoviev, A., Skabkin, M. A., Elemento, O., Pestova, T. V., Qian, S.-B., & Jaffrey, S. R. (2015) · Cell · doi:10.1016/j.cell.2015.10.012 · Cited by 1,806
Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome
Linder, B., Grozhik, A. V., Olarerin-George, A. O., Meydan, C., Mason, C. E., & Jaffrey, S. R. (2015) · Nature Methods · doi:10.1038/nmeth.3453 · Cited by 1,569
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Yankova, E., Blackaby, W., Albertella, M., Rak, J., De Braekeleer, E., Tsagkogeorga, G., Pilka, E. S., Aspris, D., Leggate, D., Hendrick, A. G., et al. (2021) · Nature · doi:10.1038/s41586-021-03536-w · Cited by 1,352
Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control
Barbieri, I., Tzelepis, K., Pandolfini, L., Shi, J., Millán-Zambrano, G., Robson, S. C., Aspris, D., Migliori, V., Bannister, A. J., Han, N., et al. (2017) · Nature · doi:10.1038/nature24678 · Cited by 1,086
Zc3h13 Regulates Nuclear RNA m6A Methylation and Mouse Embryonic Stem Cell Self-Renewal
Wen, J., Lv, R., Ma, H., Shen, H., He, C., Wang, J., Jiao, F., Liu, H., Yang, P., Tan, L., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.02.015 · Cited by 941
Self-citationMechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD
Ferenbach, D. A., & Bonventre, J. V. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.3 · Cited by 876
Wang, Q., Chen, C., Ding, Q., Zhao, Y., Wang, Z., Chen, J., Jiang, Z., Zhang, Y., Xu, G., Zhang, J., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319639 · Cited by 862
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Li, T., Hu, P.-S., Zuo, Z., Lin, J.-F., Li, X., Wu, Q.-N., Chen, Z.-H., Zeng, Z.-L., Wang, F., Zheng, J., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1038-7 · Cited by 799
Self-citationFailed Tubule Recovery, AKI-CKD Transition, and Kidney Disease Progression
Venkatachalam, M. A., Weinberg, J. M., Kriz, W., & Bidani, A. K. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015010006 · Cited by 744
Dominissini, D., Moshitch-Moshkovitz, S., Salmon-Divon, M., Amariglio, N., & Rechavi, G. (2013) · Nature Protocols · doi:10.1038/nprot.2012.148 · Cited by 710
Liu, J., Dou, X., Chen, C., Chen, C., Liu, C., Xu, M. M., Zhao, S., Shen, B., Gao, Y., Han, D., et al. (2020) · Science · doi:10.1126/science.aay6018 · Cited by 709
Inflammatory processes in renal fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.114 · Cited by 690
Self-citationChen, Y., Peng, C., Chen, J., Chen, D., Yang, B., He, B., Hu, W., Zhang, Y., Liu, H., Dai, L., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1053-8 · Cited by 630
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
Niu, Y., Lin, Z., Wan, A., Chen, H., Liang, H., Sun, L., Wang, Y., Li, X., Xiong, X.-F., Wei, B., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1004-4 · Cited by 593
Self-citationMettl3-mediated mRNA m6A methylation promotes dendritic cell activation
Wang, H., Hu, X., Huang, M., Liu, J., Gu, Y., Ma, L., Zhou, Q., & Cao, X. (2019) · Nature Communications · doi:10.1038/s41467-019-09903-6 · Cited by 503
Bartosovic, M., Molares, H. C., Gregorova, P., Hrossova, D., Kudla, G., & Vanacova, S. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx778 · Cited by 434
Guo, X., Li, K., Jiang, W., Hu, Y., Xiao, W., Huang, Y., Feng, Y., Pan, Q., & Wan, R. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01158-w · Cited by 398
Zhu, S., Pan, W., Song, X., Liu, Y., Shao, X., Tang, Y., Liang, D., He, D., Wang, H., Liu, W., et al. (2012) · Nature Medicine · doi:10.1038/nm.2815 · Cited by 396
N6-methyladenosine regulates glycolysis of cancer cells through PDK4
Li, Z., Peng, Y., Li, J., Chen, Z., Chen, F., Tu, J., Lin, S., & Wang, H. (2020) · Nature Communications · doi:10.1038/s41467-020-16306-5 · Cited by 323
Self-citationLandscape and Regulation of m6A and m6Am Methylome across Human and Mouse Tissues
Liu, J., Li, K., Cai, J., Zhang, M., Zhang, X., Xiong, X., Meng, H., Xu, X., Huang, Z., Peng, J., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.09.032 · Cited by 299
c-Jun, at the crossroad of the signaling network
Meng, Q., & Xia, Y. (2011) · Protein & Cell · doi:10.1007/s13238-011-1113-3 · Cited by 298
Meng, X.-M., Ren, G.-L., Gao, L., Yang, Q., Li, H.-D., Wu, W.-F., Huang, C., Zhang, L., Lv, X.-W., & Li, J. (2018) · Laboratory Investigation · doi:10.1038/labinvest.2017.120 · Cited by 203
Self-citationRaup-Konsavage, W. M., Wang, Y., Wang, W. W., Feliers, D., Ruan, H., & Reeves, W. B. (2018) · Kidney International · doi:10.1016/j.kint.2017.08.014 · Cited by 200
METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA
Wu, Z., Shi, Y., Lu, M., Song, M., Yu, Z., Wang, J., Wang, S., Ren, J., Yang, Y.-G., Liu, G.-H., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa816 · Cited by 189
Self-citationm6A promotes R-loop formation to facilitate transcription termination
Yang, X., Liu, Q.-L., Xu, W., Zhang, Y.-C., Yang, Y., Ju, L.-F., Chen, J., Chen, Y.-S., Li, K., Ren, J., et al. (2019) · Cell Research · doi:10.1038/s41422-019-0235-7 · Cited by 180
Regulatory Role of N6-methyladenosine (m6A) Methylation in RNA Processing and Human Diseases
Wei, W., Ji, X., Guo, X., & Ji, S. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25967 · Cited by 168
Stimulated kidney tubular epithelial cells express membrane associated and secreted TNFα
Jevnikar, A. M., Brennan, D. C., Singer, G. G., Heng, J. E., Maslinski, W., Wuthrich, R. P., Glimcher, L. H., & Kelley, V. E. (1991) · Kidney International · doi:10.1038/ki.1991.201 · Cited by 154
Mapperley, C., van de Lagemaat, L. N., Lawson, H., Tavosanis, A., Paris, J., Campos, J., Wotherspoon, D., Durko, J., Sarapuu, A., Choe, J., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20200829 · Cited by 140
The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer
Liu, Y., Chen, X., Cheng, R., Yang, F., Yu, M., Wang, C., Cui, S., Hong, Y., Liang, H., Liu, M., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-017-0751-3 · Cited by 136
Self-citationZong, X., Zhao, J. C., Wang, H., Lu, Z., Wang, F., Du, H., & Wang, Y. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1801151 · Cited by 117
Self-citationA methionine-Mettl3-N-methyladenosine axis promotes polycystic kidney disease
Ramalingam, H., Kashyap, S., Cobo-Stark, P., Flaten, A., Chang, C.-M., Hajarnis, S. S., Hein, K. Z., Lika, J., Warner, G. M., Espíndola‐Netto, J. M., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.03.024 · Cited by 100
TAK1 regulates hepatic cell survival and carcinogenesis
Roh, Y. S., Song, J., & Seki, E. (2014) · Journal of Gastroenterology · doi:10.1007/s00535-013-0931-x · Cited by 95
Wang, J.-N., Yang, Q., Yang, C., Cai, Y.-T., Tian, X., Gao, L., Wang, F., Chen, X., Liu, X., He, X., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101479 · Cited by 95
Self-citationFan, L., Lei, H., Zhang, S., Peng, Y., Fu, C., Shu, G., & Yin, G. (2020) · Theranostics · doi:10.7150/thno.43198 · Cited by 92
Yu, J.-T., Hu, X., Chen, H., Yang, Q., Li, H.-D., Dong, Y., Zhang, Y., Wang, J., Jin, J., Wu, Y., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105286 · Cited by 90
Self-citationWang, J.-N., Liu, M.-M., Wang, F., Wei, B., Yang, Q., Cai, Y.-T., Chen, X., Liu, X., Jiang, L., Li, C., et al. (2019) · Clinical Science · doi:10.1042/cs20190599 · Cited by 87
Self-citationCircular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis
Chen, X., Li, H.-D., Bu, F., Li, X., Chen, Y., Zhu, S., Wang, J., Chen, S., Sun, Y.-Y., Pan, X., et al. (2020) · Theranostics · doi:10.7150/thno.42423 · Cited by 85
Self-citationUSP15 potentiates NF‐κB activation by differentially stabilizing TAB2 and TAB3
Zhou, Q., Cheng, C., Wei, Y., Yang, J. X., Zhou, W., Song, Q., Ke, M., Yan, W., Zheng, L., Zhang, Y., et al. (2020) · FEBS Journal · doi:10.1111/febs.15202 · Cited by 74
Pentraxin-2 suppresses c-Jun/AP-1 signaling to inhibit progressive fibrotic disease
Nakagawa, N., Barron, L., Gomez, I. G., Johnson, B. G., Roach, A. M., Kameoka, S., Jack, R. M., Lupher, M. L., Gharib, S. A., & Duffield, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.87446 · Cited by 59 · cited 1×
“c-Jun has previously been shown to be involved in renal inflammation and fibrosis (28, 29).”
BackgroundGrimsey, N. J., Lin, Y., Narala, R., Rada, C. C., Mejia-Pena, H., & Trejo, J. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007495 · Cited by 51
Stabilization of the TAK1 adaptor proteins TAB2 and TAB3 is critical for optimal NF‐κB activation
Braun, H., & Staal, J. (2020) · FEBS Journal · doi:10.1111/febs.15210 · Cited by 23
Li, Q., Chen, L., Luo, C. H., ChenYan, Ge, J., Zhu, Z., Wang, K., Yu, X., Lei, J., Liu, T., et al. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111975 · Cited by 15
Cited by
Cisplatin nephrotoxicity: new insights and therapeutic implications
Tang, C., Livingston, M. J., Safirstein, R., & Dong, Z. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00631-7 · Cited by 548
Epigenetics-targeted drugs: current paradigms and future challenges
Dai, W., Qiao, X., Fang, Y., Guo, R., Bai, P., Liu, S., Li, T., Jiang, Y., Wei, S., Na, Z., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02039-0 · Cited by 339
Wu, D., Spencer, C. B., Ortoga, L., Zhang, H., & Miao, C. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103194 · Cited by 310
De Jesus, D. F., Zhang, Z., Brown, N. K., Li, X., Xiao, L., Hu, J., Gaffrey, M. J., Fogarty, G., Kahraman, S., Wei, J., et al. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01368-0 · Cited by 56
Jiang, L., Roberts, R., Wong, M., Zhang, L., Webber, C. J., Libera, J., Wang, Z., Kilci, A., Jenkins, M., Ortiz, A. R., et al. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1372297 · Cited by 15
Self-citation
Metadata
- Authors
- Wang, J.-N., Wang, F., Ke, J., Li, Z., Xu, C.-H., Yang, Q., Chen, X., He, X.-Y., He, Y., Suo, X.-G., Li, C., Yu, J.-T., Jiang, L., Ni, W.-J., Jin, J., Liu, M.-M., Shao, W., Yang, C., Gong, Q., Chen, H.-Y., Li, J., Wu, Y.-G., & Meng, X.-M.
- Venue
- Science Translational Medicine
- Published
- 2022-04-13
- Volume
- 14
- Issue
- 640
- Pages
- eabk2709-eabk2709
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W4224015596
- Cited by
- 298
- References
- 46
- FWCI
- 17.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.